Pediatric patients on ketogenic diet undergoing general anesthesia-a medical record review

Elif Soysal1, Heike Gries2, Carter Wray1

  • 1Pediatric Neurology, Oregon Health and Sciences University, 3181 SW Sam Jackson Park Rd, Portland, OR 97539, USA.

Insights

General anesthesia appears safe for pediatric patients on a ketogenic diet (KD) for epilepsy. While minor complications occurred, they were mild and resolved quickly, indicating manageable risks for this population.

Area of Science:

  • Anesthesiology
  • Pediatric Neurology
  • Medical Nutrition Therapy

Background:

  • The ketogenic diet (KD) is an established therapy for intractable pediatric epilepsy.
  • Anesthesia management for children on KD requires careful consideration due to potential metabolic alterations.

Purpose of the Study:

  • To evaluate the safety and identify guidelines for anesthesia management in pediatric patients undergoing general anesthesia while on a ketogenic diet (KD).

Main Methods:

  • Retrospective review of medical records for pediatric patients (ages 1-15) on KD who received general anesthesia between 2009 and 2014.
  • Analysis included patient demographics, seizure history, procedure type, perioperative blood chemistry, anesthetic agents, and postoperative complications.

Main Results:

  • 33 procedures were performed on 24 pediatric patients on KD. Three patients experienced complications potentially related to KD and anesthesia: increased seizures, metabolic acidosis, and respiratory distress with increased seizure activity.
  • These complications were generally mild, with seizure activity returning to baseline within 24 hours for two patients.

Conclusions:

  • General anesthesia is relatively safe for pediatric patients on a ketogenic diet (KD).
  • Careful fluid management (e.g., considering normal saline cautiously) and awareness of potential drug-induced changes in ketogenic status are crucial.
  • Monitoring for metabolic acidosis and seizure activity is recommended during the perioperative period.
Abstract

Related Concept Videos

Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
1.4K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
306
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
605
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
346
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
411
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
2.1K